Vasilios Perifanis

Dr. Vasilios Perifanis


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2003 in Clinical and Laboratory Haematology
Verified
Journal Article
Closed access
PDF file
GKG. Koliakos
G. Koliakos
FPF. Papachristou
F. Papachristou
AKA. Koussi
A. Koussi
VPVasilios Perifanis
Vasilios Perifanis
ITI. Tsatra
I. Tsatra
MAM. Athanasiou
M. Athanasiou

1 May 1996 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
MKMaria‐Christina Kyrtsonis
Maria‐Christina Kyrtsonis
GDGeorges Dedoussis
Georges Dedoussis
CZConstantin Zervas
Constantin Zervas
VPVasilios Perifanis
Vasilios Perifanis
CBConstantin Baxevanis
Constantin Baxevanis
AMAlice Maniatis
Alice Maniatis

1 January 2019 in Hematology
Verified
Journal Article
Open access
CDChristos Demosthenous
Christos Demosthenous
EVEfthymia Vlachaki
Efthymia Vlachaki
CAChrysa Apostolou
Chrysa Apostolou
PEPerla Eleftheriou
Perla Eleftheriou
AKAggeliki Kotsiafti
Aggeliki Kotsiafti
Pantelis A SarafidisPantelis A Sarafidis
Pantelis A Sarafidis
Objectives: Beta-thalassemias are a group of recessively autosomal inherited disorders of hemoglobin synthesis, which, due to mutations of the beta-globin gene, lead to various degrees of defective beta-chain production, an imbalance in alpha/beta-globin chain synthesis, ineffective erythropoiesis, and anemia. Improved survival in thalassemic patients has led to the emergence of previously unrecognized complications, such as renal disease. Methods: A comprehensive literature review through PubMed was undertaken to summarize the published evidence on the epidemiology and pathophysiology of renal disease in thalassemia. Literature sources published in English since 1990 were searched, using the terms beta-thalassemia, renal disease. Results: Renal disease is considered to be the 4th cause of morbidity among patients with transfusion dependent thalassemia. Chronic anemia, hypoxia and iron overload are the main mechanisms implicated in development of renal injury, whereas several studies also suggested a contributive role of iron chelators. Discussion and Conclusion: Kidney disease may develop through progressive renal tubular and glomerular damage; thus, its early recognition is important in order to prevent and/or reverse deterioration. This review will provide an insight on the involved mechanisms implicated in kidney disease in thalassemic patients and will discuss the updates on diagnosis and prevention of renal complications in thalassemia.

1 December 2012 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
GKGeorgia D. Kaiafa
Georgia D. Kaiafa
ZSZoi Saouli
Zoi Saouli
Michael D. DiamantidisMichael D. Diamantidis
Michael D. Diamantidis
ZKZisis Kontoninas
Zisis Kontoninas
VVVirginia Voulgaridou
Virginia Voulgaridou
VPVasilios Perifanis
Vasilios Perifanis
1

24 April 2015 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
PNP. Nemtsas
P. Nemtsas
MAMarianthi A. Arnaoutoglou
Marianthi A. Arnaoutoglou
VPVasilios Perifanis
Vasilios Perifanis
EKEffrosyni Koutsouraki
Effrosyni Koutsouraki
AOA. Orologas
A. Orologas

1 October 2009 in Vascular Health and Risk Management
Verified
Journal Article
Open access
Konstantinos TziomalosKonstantinos Tziomalos
Konstantinos Tziomalos
SVSofia Vakalopoulou
Sofia Vakalopoulou
VPVasilios Perifanis
Vasilios Perifanis
VGVassilia Garipidou
Vassilia Garipidou
Peer reviewed article authored by (Konstantinos Tziomalos, Sofia Vakalopoulou, Vassilios Perifanis, et al). Read article or submit your manuscript for publishing.